Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the monthly archives: September, 2018

We are pleased to present below all posts archived in 'September, 2018'. If you still can't find what you are looking for, try using the search box.

Scotland’s Life Sciences Start-Ups to benefit from BioCity’s specialist support

Life sciences incubator, BioCity, has won a contract tendered by Scottish Enterprise to provide specialist support and advice to all its life science start-ups in Scotland.The minimum three-year contract will see BioCity provide specialist coaches and consultants to help and support the next generation of life science start-ups in Scotland to achieve their potential.

Read the rest of entry »

BioHub Birmingham® develops new incubator space to meet increasing demand for biomedical facilities

The BioHub Birmingham® is constructing 5,000sq ft of self-contained laboratory and office suites to meet an increasing demand for biomedical incubator space.

The BioHub opened in 2015 and its shared facilities on the ground floor are now operating at capacity. It is managed by University of Birmingham Enterprise and is located at the Birmingham Research Park, which provides incubation services and facilities, as well as commercial office space for biomedical and hi-tech companies. 

Read the rest of entry »

Oxford MEStar wins funding to develop 3D printed medical implants

Oxford MEStar, the Oxford University bioengineering spinout company, today announced that it has been awarded funding to take part in a 36-month, € 6.84 Million project under the EU Interreg 2 Seas initiative. 

Read the rest of entry »

Government Confirms £1bn Funding for British Innovation

CPI has received a share of £1bn Government funding to support next-generation manufacturing work across the High Value Manufacturing Catapult programme.

Read the rest of entry »

Diamond Pharma Services shortlisted for two prestigious industry awards.

Diamond are proud to announce that they have been shortlisted in two categories in the TOPRA (The Organisation for Professionals in Regulatory Affairs) awards recognising their commitment to innovation and excellence in customer service.

Read the rest of entry »

Discovery follows successful collaboration between Selcia, Cypralis and Gilead Sciences

On Monday 17 September 2018 OBN Members Selcia and Cypralis announced that their collaboration with Gilead has resulted in the identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity. 

Read the rest of entry »

Isansys announces that its advanced wireless patient monitoring platform granted key US patent

Isansys Lifecare, developer of the world’s most advanced real-time patient data collection and analysis platform, has been granted a US patent covering a key feature of its Lifetouch cardiac sensor

Read the rest of entry »

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™Lung Liquid Biopsy Test

Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients with Advanced Non-Small-Cell Lung Cancer . Inivata, a leader in liquid biopsy,  announced on 13 September that Palmetto GBA, a Medicare Administrative Contractor that  evaluates diagnostic technology through its laboratory technology assessment group, MolDx, has published a draft local coverage determination (LCD) for the InVisionFirst-Lung test.

Read the rest of entry »

Wickham Laboratories will be exhibit at Medical Technology Ireland 2018

Wickham Laboratories Ltd will be exhibiting at the Medical Technology Ireland Conference on the 26 and 27 of September at the Galway Racecourse in Galway, Ireland. 

Read the rest of entry »

Arecor secures £6m investment for the clinical development of its diabetes speciality pharma portfolio

On 10 September 2018 Arecor Ltd, the UK-based leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, announced that it has secured £6.0 million of investment from new and existing investors for the clinical development of the Company’s speciality pharma portfolio of proprietary diabetes products.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.